go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Connecticut rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $4,365 · 10th–90th $0$6,7610%20%10th90th$4,365Professionalmedian $3,548 · 10th–90th $2,884$4,0740%50%10th90th$3,548$0.0$0.2$2.0$20.0$200.0$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$4,365.16
Median
$4,365.16
Typical High
$5,623.41
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,884.03
Median
$3,548.13
Typical High
$3,548.13
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$3,890.45
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.03
Median
$3,467.37
Typical High
$10,471.29
Cigna
Setting
Facility
Modifier
Global
Typical Low
$4,897.79
Median
$4,897.79
Typical High
$6,760.83
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
ConnectiCare
Setting
Professional
Modifier
Global
Typical Low
$2,951.21
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Professional
Modifier
Global
Typical Low
$2,951.21
Median
$4,168.69
Typical High
$4,168.69